Abstract
Calcium oxide (CaO) sorbents have been recently used for removal of CO2 gases in fossil fuel-fired power plant. However, there are some limitations of CaO in CO2 capturing such as rapid loss of activity during the capture cycles, which is a result of sintering, attrition, and consequent elutriation. Therefore, this paper has demonstrated a novel synthesis method to produce CaO at room temperature to avoid abovementioned drawbacks. In addition, introduction of ionic surfactant of sodium dodecyl sulfate to the CaO formation solution has shown a positive result of formation of homogeneous spherical particle with a mean Z-average diameter of 345.2 nm and polydispersion index (PDI) of 0.335 by dynamical light scattering measurement. Subjected to a high calcination temperature of 1200oC, developed CaO is able to maintain a CO2 uptake capacity of 0.1025 gCO2/gsorbent under 30 minutes of carbonation time. Despite its lower CO2 uptake capacity compared to maximum theoretical limit of 0.78 gCO2/gsorbent, CaO particles is able to withstand a high calcination temperature of 1200oC and reported a particle size distribution ranged from 0.4 - 1.2 µm after calcination which is just slightly larger than fresh developed CaO. Given that such small narrow distributed size of CaO, developed CaO at room temperature is good for packed-bed reactor in calcium looping processes and more studies are required to find a suitable support for fluidized bed reactor type. This successful synthesis story of CaO particle at room temperature has unraveled the possibility to develop nanosized CaO at room temperature in order to achieve high CO2 uptake capacity while enjoying its superior thermal stability over multiple carbonation/calcination cycles.
Highlights
The rate and the extent of drug dissolution and its absorption depend on the characteristics of the active pharmaceutical ingredient (API) as well as the dosage form properties
Dissolution of drug from oral solid dosage forms is a necessary criterion for drug bioavailability
The products were purchased from pharmacies in Buenos Aires (Argentina)
Summary
The rate and the extent of drug dissolution and its absorption depend on the characteristics of the active pharmaceutical ingredient (API) as well as the dosage form properties. In the case of immediate-release solid dosage forms such as tablets, dissolution test are used to evaluate batches and can be used to evaluate new and existing formulations and possibly to assess the impact of certain changes in the formulation and manufacturing process [2]. Based on these consideration, dissolution test are largely used to assure the quality of the pharmaceutical product. In our Country, there is a Disposition of our Health Authorities to evaluate bioavailability and bioequivalence of the market pharmaceutical products containing Furosemide [3]. There have been no studies about bioavailability and bioequivalence of the marketed products
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Applied Solution Chemistry and Modeling
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
